González D

ANIMA Group. Institut de Recerca Sant Joan de Déu (IRSJD), Esplugues de Llobregat, Spain.

8 papers · ORCID

ArticlePsilocybin

Time to embrace the whole: considering the replacement of psilocybin with <i>Psilocybe</i> spp. in psychedelic research and therapy.

Ona G, Llagostera C, Alvarez O +3

Europe PMC2026
ArticleAyahuasca

Personality, not cognition, distinguishes chronic ayahuasca and cannabis users from non-users.

Bouso JC, Andión O, Estévez SF +6

Europe PMC2026
ArticleAyahuasca

Ayahuasca-assisted meaning reconstruction therapy as an early resource for bereavement: a non-randomized clinical trial.

Soto-Angona O, Andión O, Sabucedo P +5

Europe PMC2025
ArticleAyahuasca

Corrigendum: Ayahuasca-assisted meaning reconstruction therapy for grief: a non-randomized clinical trial protocol.

Sabucedo P, Andión O, Neimeyer RA +5

Europe PMC2025
ArticleAyahuasca

Ayahuasca-assisted meaning reconstruction therapy for grief: a non-randomized clinical trial protocol.

Sabucedo P, Andión O, Neimeyer RA +5

Europe PMC2024
ArticleAyahuasca

Restorative Retelling for Processing Psychedelic Experiences: Rationale and Case Study of Complicated Grief.

González D, Aixalà MB, Neimeyer RA +3

Europe PMC2022
ArticleMescaline

Acute Pharmacological Effects of 2C-B in Humans: An Observational Study.

Papaseit E, Farré M, Pérez-Mañá C +5

Europe PMC2018
ArticlePsychedelics

Acute Effects of the Novel Psychoactive Drug 2C-B on Emotions.

González D, Torrens M, Farré M

Europe PMC2015